Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $65.45 million. The enterprise value is $54.22 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 59.50 million shares outstanding. The number of shares has increased by 1.14% in one year.
| Current Share Class | 59.50M |
| Shares Outstanding | 59.50M |
| Shares Change (YoY) | +1.14% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 11.67% |
| Owned by Institutions (%) | 4.13% |
| Float | 42.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.36 |
| Forward PS | n/a |
| PB Ratio | 7.77 |
| P/TBV Ratio | 12.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.65 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -146.92% and return on invested capital (ROIC) is -90.26%.
| Return on Equity (ROE) | -146.92% |
| Return on Assets (ROA) | -46.32% |
| Return on Invested Capital (ROIC) | -90.26% |
| Return on Capital Employed (ROCE) | -396.42% |
| Revenue Per Employee | $472,943 |
| Profits Per Employee | -$576,971 |
| Employee Count | 35 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Equillium has paid $361,000 in taxes.
| Income Tax | 361,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.39% in the last 52 weeks. The beta is 1.88, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | +46.39% |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 0.83 |
| Relative Strength Index (RSI) | 36.37 |
| Average Volume (20 Days) | 527,123 |
Short Selling Information
The latest short interest is 779,644, so 1.31% of the outstanding shares have been sold short.
| Short Interest | 779,644 |
| Short Previous Month | 2.18M |
| Short % of Shares Out | 1.31% |
| Short % of Float | 1.85% |
| Short Ratio (days to cover) | 1.11 |
Income Statement
In the last 12 months, Equillium had revenue of $16.55 million and -$20.19 million in losses. Loss per share was -$0.57.
| Revenue | 16.55M |
| Gross Profit | 16.55M |
| Operating Income | -20.48M |
| Pretax Income | -19.83M |
| Net Income | -20.19M |
| EBITDA | -20.34M |
| EBIT | -20.48M |
| Loss Per Share | -$0.57 |
Full Income StatementBalance Sheet
The company has $11.50 million in cash and $259,000 in debt, giving a net cash position of $11.24 million or $0.19 per share.
| Cash & Cash Equivalents | 11.50M |
| Total Debt | 259,000 |
| Net Cash | 11.24M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 5.06M |
| Book Value Per Share | 0.14 |
| Working Capital | 4.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.14 million and capital expenditures -$8,000, giving a free cash flow of -$22.15 million.
| Operating Cash Flow | -22.14M |
| Capital Expenditures | -8,000 |
| Free Cash Flow | -22.15M |
| FCF Per Share | -$0.37 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -123.69% and -122.00%.
| Gross Margin | 100.00% |
| Operating Margin | -123.69% |
| Pretax Margin | -119.82% |
| Profit Margin | -122.00% |
| EBITDA Margin | -122.88% |
| EBIT Margin | -123.69% |
| FCF Margin | n/a |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.14% |
| Shareholder Yield | -1.14% |
| Earnings Yield | -30.85% |
| FCF Yield | -33.83% |
Analyst Forecast
The average price target for Equillium is $1.00, which is -9.09% lower than the current price. The consensus rating is "Hold".
| Price Target | $1.00 |
| Price Target Difference | -9.09% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 2.26% |
| EPS Growth Forecast (5Y) | -22.99% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Equillium has an Altman Z-Score of -25.13. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.13 |
| Piotroski F-Score | n/a |
